BeiGene (BGNE)
(Delayed Data from NSDQ)
$198.50 USD
+0.34 (0.17%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $198.56 +0.06 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Income Statements
Fiscal Year end for BeiGene, Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,459 | 1,416 | 1,176 | 309 | 428 |
Cost Of Goods | 380 | 286 | 165 | 71 | 71 |
Gross Profit | 2,079 | 1,129 | 1,011 | 238 | 357 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,287 | 2,919 | 2,450 | 1,896 | 1,317 |
Income After Depreciation & Amortization | -1,208 | -1,790 | -1,439 | -1,658 | -960 |
Non-Operating Income | 382 | -171 | 16 | 39 | 16 |
Interest Expense | 0 | 0 | 16 | 0 | 0 |
Pretax Income | -826 | -1,961 | -1,439 | -1,618 | -944 |
Income Taxes | 56 | 43 | -25 | -18 | 7 |
Minority Interest | 0 | 0 | 0 | -4 | -2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -882 | -2,004 | -1,413 | -1,601 | -951 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -882 | -2,004 | -1,413 | -1,597 | -949 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1,120 | -1,723 | -1,392 | -1,740 | -941 |
Depreciation & Amortization (Cash Flow) | 88 | 66 | 46 | -82 | 19 |
Income After Depreciation & Amortization | -1,208 | -1,790 | -1,439 | -1,658 | -960 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 104.39 | 103.13 | 92.79 | 83.47 | 60.05 |
Diluted EPS Before Non-Recurring Items | -8.45 | -19.43 | -15.23 | -19.13 | -15.80 |
Diluted Net EPS (GAAP) | -8.45 | -19.43 | -15.23 | -19.13 | -15.80 |
Fiscal Year end for BeiGene, Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 929.17 | 751.65 | 634.41 | 781.31 | 595.26 |
Cost Of Goods | 138.13 | 124.94 | 105.83 | 96.31 | 95.99 |
Gross Profit | 791.03 | 626.72 | 528.58 | 685.00 | 499.27 |
SG&A, R&D, and Dept/Amort Expenses | 898.20 | 888.07 | 912.38 | 818.97 | 817.98 |
Income After SG&A, R&D, and Dept/Amort Expenses | -107.17 | -261.35 | -383.80 | -133.97 | -318.71 |
Non-Operating Income | 1.24 | 17.92 | 33.02 | 363.31 | -48.75 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -105.92 | -243.43 | -350.77 | 229.34 | -367.46 |
Income Taxes | 14.49 | 7.72 | 16.78 | 13.93 | 13.67 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -120.41 | -251.15 | -367.55 | 215.41 | -381.14 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -120.41 | -251.15 | -367.55 | 215.41 | -381.14 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 104.70 | 104.27 | 104.08 | 106.95 | 104.63 |
Diluted EPS Before Non-Recurring Items | -1.15 | -2.41 | -3.53 | 2.01 | -3.64 |
Diluted Net EPS (GAAP) | -1.15 | -2.41 | -3.48 | 2.01 | -3.64 |